A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone
Combination therapy with levothyroxine and liothyronine (LT4 + LT3) and desiccated thyroid extract (DTE) make up >10% of new thyroid hormone (TH) prescriptions in the US. To assess healthcare utilization related to cardiovascular disease (CVD) and bone health (BH) events (atrial fibrillation [AF]...
Saved in:
Published in | The journal of clinical endocrinology and metabolism |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
United States
25.10.2023
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Abstract | Combination therapy with levothyroxine and liothyronine (LT4 + LT3) and desiccated thyroid extract (DTE) make up >10% of new thyroid hormone (TH) prescriptions in the US.
To assess healthcare utilization related to cardiovascular disease (CVD) and bone health (BH) events (atrial fibrillation [AF], heart failure [HF], myocardial infarction [MI], stroke, and osteoporosis/fractures [FX]) in participants taking LT4 + LT3 or DTE surveyed in the Medical Expenditure Panel Survey (MEPS) database.
Multi-year cross-sectional analysis examining 5,437 participants (≥18 years old) treated with LT4, LT4 + LT3, or DTE between 2016 and 2020. Healthcare utilization was assessed through outpatient, emergency, and hospital visits for AF, HF, MI, stroke, FX, and a composite index. A weighted analysis provided national estimates of healthcare utilization parameters. Utilization was re-analyzed following propensity score-based matching to balance sociodemographic and clinical covariates between treatment groups. Additionally, provider type and specialty data were obtained from visits associated with TH prescriptions.
5,106 participants were treated with LT4 monotherapy, 252 with DTE, and 79 with LT4 + LT3. Prevalence of combined outpatient CVD and BH-related care utilization was lower amongst DTE/LT4 + LT3 vs LT4 users (3.5% vs 7.7%; p = 0.008). There were no differences in emergency/hospital events. After covariate balancing, CVD and BH-related care utilization was similar between groups in outpatient and emergency/hospital settings. LT3 and DTE made up 7.6% of all TH prescriptions. For visits associated with DTE prescriptions, nurse practitioners and alternative medicine professionals were more likely to be identified as the primary provider type.
No significant differences in CVD and BH-related healthcare utilization were identified between LT4 and DTE/LT4 + LT3 users after covariate balancing. Non-MD providers were more likely to prescribe DTE. |
---|---|
AbstractList | Combination therapy with levothyroxine and liothyronine (LT4 + LT3) and desiccated thyroid extract (DTE) make up >10% of new thyroid hormone (TH) prescriptions in the US.
To assess healthcare utilization related to cardiovascular disease (CVD) and bone health (BH) events (atrial fibrillation [AF], heart failure [HF], myocardial infarction [MI], stroke, and osteoporosis/fractures [FX]) in participants taking LT4 + LT3 or DTE surveyed in the Medical Expenditure Panel Survey (MEPS) database.
Multi-year cross-sectional analysis examining 5,437 participants (≥18 years old) treated with LT4, LT4 + LT3, or DTE between 2016 and 2020. Healthcare utilization was assessed through outpatient, emergency, and hospital visits for AF, HF, MI, stroke, FX, and a composite index. A weighted analysis provided national estimates of healthcare utilization parameters. Utilization was re-analyzed following propensity score-based matching to balance sociodemographic and clinical covariates between treatment groups. Additionally, provider type and specialty data were obtained from visits associated with TH prescriptions.
5,106 participants were treated with LT4 monotherapy, 252 with DTE, and 79 with LT4 + LT3. Prevalence of combined outpatient CVD and BH-related care utilization was lower amongst DTE/LT4 + LT3 vs LT4 users (3.5% vs 7.7%; p = 0.008). There were no differences in emergency/hospital events. After covariate balancing, CVD and BH-related care utilization was similar between groups in outpatient and emergency/hospital settings. LT3 and DTE made up 7.6% of all TH prescriptions. For visits associated with DTE prescriptions, nurse practitioners and alternative medicine professionals were more likely to be identified as the primary provider type.
No significant differences in CVD and BH-related healthcare utilization were identified between LT4 and DTE/LT4 + LT3 users after covariate balancing. Non-MD providers were more likely to prescribe DTE. |
Author | Bianco, Antonio C Ettleson, Matthew D Penna, Gustavo C |
Author_xml | – sequence: 1 givenname: Gustavo C orcidid: 0000-0003-2125-7051 surname: Penna fullname: Penna, Gustavo C organization: Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism, The University of Chicago, Chicago, IL 60637, USA – sequence: 2 givenname: Antonio C orcidid: 0000-0001-7737-6813 surname: Bianco fullname: Bianco, Antonio C organization: Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism, The University of Chicago, Chicago, IL 60637, USA – sequence: 3 givenname: Matthew D orcidid: 0000-0003-0328-1752 surname: Ettleson fullname: Ettleson, Matthew D organization: Section of Adult and Pediatric Endocrinology, Diabetes & Metabolism, The University of Chicago, Chicago, IL 60637, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37878964$$D View this record in MEDLINE/PubMed |
BookMark | eNqFjs1uwjAQhC3Uip_CK6B9gUikhIYcEQLxAL2jTWzqrRwb7Tqg8PQYCc5cZg4z32gm6sMHbwZqnFfFKivzqhypicj_YpEXxWo5VKNluS7X1U8xVryBhoNIJqaJFDw6wCS9kEA4QYOsKVxQms4hp0hDnbbBGnTRptRAF8nRDR8w6I7J_0Fkg7E1PsKVooVoew6kwQZuEzxVnyd0YmZP_1Lz_e53e8jOXd0afTwztcj98XXy-23hDug3TGQ |
ContentType | Journal Article |
Copyright | The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
DBID | NPM |
DatabaseName | PubMed |
DatabaseTitle | PubMed |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
ExternalDocumentID | 37878964 |
Genre | Journal Article |
GrantInformation_xml | – fundername: NIDDK NIH HHS grantid: R01 DK058538 |
GroupedDBID | --- -~X .55 .XZ 08P 0R~ 18M 34G 354 39C 4.4 48X 53G 5GY 5RS 5YH 8F7 AABZA AACZT AAIMJ AAPQZ AAPXW AARHZ AAUAY AAVAP AAWTL ABBLC ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABWST ABXVV ACGFO ACGFS ACPRK ACUTJ ACYHN ADBBV ADGKP ADGZP ADHKW ADQBN ADRTK ADVEK AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFZL AFGWE AFOFC AFRAH AFXAL AGINJ AGKRT AGQXC AGUTN AHMBA AJEEA ALMA_UNASSIGNED_HOLDINGS APIBT ARIXL ASPBG ATGXG AVWKF AZFZN BAWUL BAYMD BCRHZ BEYMZ BSWAC BTRTY C45 CDBKE CS3 DAKXR DIK E3Z EBS ENERS F5P FECEO FHSFR FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 HZ~ H~9 KOP KQ8 KSI KSN L7B M5~ MHKGH MJL N9A NLBLG NOMLY NOYVH NPM O9- OAUYM OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G REU ROX ROZ TEORI TJX TLC TR2 TWZ VVN WOQ X7M YBU YFH YHG YOC ZY1 ~02 ~H1 |
ID | FETCH-pubmed_primary_378789642 |
IngestDate | Wed Oct 09 10:27:25 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | levothyroxine desiccated thyroid extract healthcare utilization hypothyroidism |
Language | English |
License | The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-pubmed_primary_378789642 |
ORCID | 0000-0003-2125-7051 0000-0003-0328-1752 0000-0001-7737-6813 |
PMID | 37878964 |
ParticipantIDs | pubmed_primary_37878964 |
PublicationCentury | 2000 |
PublicationDate | 2023-Oct-25 |
PublicationDateYYYYMMDD | 2023-10-25 |
PublicationDate_xml | – month: 10 year: 2023 text: 2023-Oct-25 day: 25 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2023 |
SSID | ssj0014453 |
Score | 4.5814543 |
Snippet | Combination therapy with levothyroxine and liothyronine (LT4 + LT3) and desiccated thyroid extract (DTE) make up >10% of new thyroid hormone (TH) prescriptions... |
SourceID | pubmed |
SourceType | Index Database |
Title | A cross-sectional analysis of cardiovascular and bone healthcare utilization during treatment with thyroid hormone |
URI | https://www.ncbi.nlm.nih.gov/pubmed/37878964 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Pa8IwFMfD3GDsMvb7t-Swm1Rcm6zm6IabDPTkwJvYpuJAE1EZbH_93ktSU2WObZciTSnVT_v68nzfbwi5DXlUk0M0HxzEUcAkrwVC4lovKYNkl8diIFGN3O7ct17ZS4_3_HKpRl2ySKrp57e6kv9QhX3AFVWyfyC7PCnsgM_AF7ZAGLa_YtyomJdcMDf9VMrI_r3HSLraaooV8kRDTjnyLV9wbWMnxMwFi77z3JZoRx8z_SYrI8httVrpG8I7rGA8sdRYZkpqiEXKuztNsgXca-PcrdBEYmXFaM8o4HrXvlj7gFUW7XwNIOAUhprot-wUYm6dctew7MoWoWmAsxLnamZDrWA8iO9sd24B1nRiaEUQSerCOpz_PLrml50PlUgprmPM62D9xv2vxBjHlZPyY9bmEian6B6QfTcZoA1L9pBsZeqI7LZdu8MxmTXoGmCaA6Z6SFcBw5CkCJh6wLQAmFrAdAmYImDqAFMH-ISUn5rdx1Zgr7g_tW4k_fy7hKdkW8Fx54RGkQwFzHwlTJ8Yz-IkFVE6EJCb1xPGZXRBzjac5HLjyBXZ8xivyc4QnqHsBhKyRVI2v_EX9ItGmA |
link.rule.ids | 786 |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+cross-sectional+analysis+of+cardiovascular+and+bone+healthcare+utilization+during+treatment+with+thyroid+hormone&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Penna%2C+Gustavo+C&rft.au=Bianco%2C+Antonio+C&rft.au=Ettleson%2C+Matthew+D&rft.date=2023-10-25&rft.eissn=1945-7197&rft_id=info%3Apmid%2F37878964&rft_id=info%3Apmid%2F37878964&rft.externalDocID=37878964 |